CONNECT WITH US
HealthTech

HealthTech

One day in the ICU without care from a pharmacist increases risk of death by 20%

Medical Xpress logo

Published on

Add as a preferred source on Google
One day in the ICU without care from a pharmacist increases risk of death by 20%

This article has been reviewed according to Science X's editorial process and policies. Editors have highlighted the following attributes while ensuring the content's credibility:

Patients in intensive care units who don't receive care from a pharmacist for even one day of their stay are 20% more likely to die, according to new research led by the University of Georgia. The work is published in the journal CHEST.

The study also found ICU patients were 10% more likely to die when pharmacists were responsible for more than 15 patients. For every one-patient increase in a pharmacist's workload, the odds of a patient dying increased by 1%.

"Critically ill patients experience an average of 1.7 medical errors per day, and nearly 80% of serious errors are caused by medications," said Susan Smith, lead author of the study and an associate professor in UGA's College of Pharmacy. Smith also practices critical care pharmacy in a local ICU. "The comprehensive medication management provided by pharmacists is essential for ensuring medication safety."

The researchers analyzed data from 213 pharmacists across 64 hospitals. The pharmacists provided information on their workload and every patient they cared for each day for 100 consecutive days, resulting in data from more than 28,000 patients. The researchers then compiled information on those patients' severity of illness, health outcomes and more.

"Previous research has shown that having pharmacists present in ICUs is good and that it improves outcomes," Smith said.



Source link

Disclaimer

We strive to uphold the highest ethical standards in all of our reporting and coverage. We TheMorningPulse.fyi want to be transparent with our readers about any potential conflicts of interest that may arise in our work. It's possible that some of the investors we feature may have connections to other businesses, including competitors or companies we write about. However, we want to assure our readers that this will not have any impact on the integrity or impartiality of our reporting. We are committed to delivering accurate, unbiased news and information to our audience, and we will continue to uphold our ethics and principles in all of our work. Thank you for your trust and support.